{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:18:50Z","timestamp":1783480730875,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]},{"name":"Guizhou Provincial Health Commission Science and Technology Fund","award":["gzwkj2023-068"],"award-info":[{"award-number":["gzwkj2023-068"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The pathogenic mechanisms underlying rheumatoid arthritis (RA) remain elusive. Lactylation, a novel post-translational modification, may regulate immune and metabolic reprogramming, underscoring the imperative to delineate lactylation-related genes (LRGs) driving RA progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>LRG expression profiles from RA patients and healthy controls were analyzed from GEO datasets. Immune infiltration and LRG-immune correlations were assessed. A machine-learning framework identified a hub LRG signature, whose metabolic and therapeutic relevance was evaluated via functional enrichment and druggability analyses. qRT-PCR validated hub gene expression in RA MH7A cells model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic profiling identified 36 differentially expressed LRGs regulating cytokine networks and immune signaling in RA. Disease stratification revealed two molecular subtypes, with Subtype B demonstrating p53 signaling and innate immunity pathway activation via gene set variation analysis (GSVA). Weighted correlation network analysis (WGCNA) identified subtype B-associated modules (504 genes). A machine learning-derived 7-LRG signature (\n                      <jats:italic>Sdc1<\/jats:italic>\n                      ,\n                      <jats:italic>Pfkfb1<\/jats:italic>\n                      ,\n                      <jats:italic>Fut8<\/jats:italic>\n                      ,\n                      <jats:italic>Adh1b<\/jats:italic>\n                      ,\n                      <jats:italic>Kif23<\/jats:italic>\n                      ,\n                      <jats:italic>Adh1c<\/jats:italic>\n                      ,\n                      <jats:italic>Pkc1<\/jats:italic>\n                      ) differentiated RA from controls (AUC 0.92). Single-cell resolution analysis localized Sdc1 to plasma cell clusters, correlating with memory B cell expansion and macrophage polarization. Hub LRGs were enriched in glucose metabolism pathways in RA, and\n                      <jats:italic>Sdc1<\/jats:italic>\n                      ,\n                      <jats:italic>Adh1b<\/jats:italic>\n                      , and\n                      <jats:italic>Adh1c<\/jats:italic>\n                      were druggable, suggesting potential therapeutic targets. qRT-PCR validation confirmed significant LRG upregulation in RA cellular models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings establish lactylation as a key modulator of immune dysregulation in RA pathogenesis. Seven LRG biomarkers were identified and validated, exhibiting dual potential as prognostic indicators and therapeutic targets through lactylation-driven pathway modulation for RA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-025-00579-1","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:52:48Z","timestamp":1778759568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification and validation of lactylation-related genes signature and immune infiltration landscape of rheumatoid arthritis based on machine learning"],"prefix":"10.1186","volume":"163","author":[{"given":"Xiaoli","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoqiao","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"issue":"10391","key":"579_CR1","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/S0140-6736(23)00457-9","volume":"401","author":"N Conrad","year":"2023","unstructured":"Conrad N, Misra S, Verbakel JY, Verbeke G, Molenberghs G, Taylor PN, et al. Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878\u201390.","journal-title":"Lancet"},{"issue":"10055","key":"579_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023\u201338.","journal-title":"Lancet"},{"issue":"13","key":"579_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: A review. JAMA. 2018;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"10086","key":"579_CR4","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338\u201348.","journal-title":"Lancet"},{"issue":"4","key":"579_CR5","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA. The science and translation of lactate shuttle theory. Cell Metab. 2018;27(4):757\u201385.","journal-title":"Cell Metab"},{"key":"579_CR6","doi-asserted-by":"crossref","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y. Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression. Int J Mol Sci. 2022; 23(19).","DOI":"10.3390\/ijms231911943"},{"issue":"7779","key":"579_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"17","key":"579_CR8","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","volume":"184","author":"S Caielli","year":"2021","unstructured":"Caielli S, Cardenas J, de Jesus AA, Baisch J, Walters L, Blanck JP, et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021;184(17):4464\u2013e44794419.","journal-title":"Cell"},{"issue":"7","key":"579_CR9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00125-024-06156-x","volume":"67","author":"J Chen","year":"2024","unstructured":"Chen J, Feng Q, Qiao Y, Pan S, Liang L, Liu Y, et al. ACSF2 and lysine lactylation contribute to renal tubule injury in diabetes. Diabetologia. 2024;67(7):1429\u201343.","journal-title":"Diabetologia"},{"key":"579_CR10","doi-asserted-by":"publisher","first-page":"107392","DOI":"10.1016\/j.intimp.2021.107392","volume":"93","author":"Z Wu","year":"2021","unstructured":"Wu Z, Ma D, Yang H, Gao J, Zhang G, Xu K, et al. Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol. 2021;93:107392.","journal-title":"Int Immunopharmacol"},{"key":"579_CR11","doi-asserted-by":"publisher","first-page":"176551","DOI":"10.1016\/j.ejphar.2024.176551","volume":"972","author":"YH Wang","year":"2024","unstructured":"Wang YH, Gao P, Wang YQ, Xu LZ, Zeng KW, Tu PF. Small-molecule targeting PKM2 provides a molecular basis of lactylation-dependent fibroblast-like synoviocytes proliferation Inhibition against rheumatoid arthritis. Eur J Pharmacol. 2024;972:176551.","journal-title":"Eur J Pharmacol"},{"issue":"7987","key":"579_CR12","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06708-y","volume":"623","author":"F Zhang","year":"2023","unstructured":"Zhang F, Jonsson AH, Nathan A, Millard N, Curtis M, Xiao Q, et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature. 2023;623(7987):616\u201324.","journal-title":"Nature"},{"key":"579_CR13","doi-asserted-by":"crossref","unstructured":"Matsuda K, Shiba N, Hiraoka K. New insights into the role of synovial fibroblasts leading to joint destruction in rheumatoid arthritis. Int J Mol Sci. 2023; 24(6).","DOI":"10.3390\/ijms24065173"},{"issue":"6","key":"579_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","volume":"79","author":"A Kerschbaumer","year":"2020","unstructured":"Kerschbaumer A, Sepriano A, Smolen JS, van der Heijde D, Dougados M, van Vollenhoven R, et al. Efficacy of Pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2020;79(6):744\u201359.","journal-title":"Ann Rheum Dis"},{"key":"579_CR15","doi-asserted-by":"publisher","first-page":"1589853","DOI":"10.3389\/fimmu.2025.1589853","volume":"16","author":"W Liu","year":"2025","unstructured":"Liu W, Yang R, Zhan Y, Yang X, Zeng H, Chen B, et al. Lactate and lactylation: emerging roles in autoimmune diseases and metabolic reprogramming. Front Immunol. 2025;16:1589853.","journal-title":"Front Immunol"},{"issue":"5\u20136","key":"579_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10495-021-01667-z","volume":"26","author":"M Li","year":"2021","unstructured":"Li M. The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseases. Apoptosis. 2021;26(5\u20136):235\u201347.","journal-title":"Apoptosis"},{"issue":"8","key":"579_CR17","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington ND, Cursons J, Rautela J. The cancer-natural killer cell immunity cycle. Nat Rev Cancer. 2020;20(8):437\u201354.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"579_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrrheum.2017.198","volume":"14","author":"RE Schmidt","year":"2017","unstructured":"Schmidt RE, Grimbacher B, Witte T. Autoimmunity and primary immunodeficiency: two sides of the same coin? Nat Rev Rheumatol. 2017;14(1):7\u201318.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"579_CR19","doi-asserted-by":"publisher","first-page":"C372","DOI":"10.1152\/ajpcell.00326.2024","volume":"327","author":"MW Hagen","year":"2024","unstructured":"Hagen MW, Setiawan NJ, Woodruff KA, Termini CM. Syndecans in hematopoietic cells and their niches. Am J Physiol Cell Physiol. 2024;327(2):C372\u20138.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"579_CR20","doi-asserted-by":"publisher","first-page":"C29","DOI":"10.1152\/ajpcell.00024.2022","volume":"323","author":"Z Yang","year":"2022","unstructured":"Yang Z, Chen S, Ying H, Yao W. Targeting syndecan-1: new opportunities in cancer therapy. Am J Physiol Cell Physiol. 2022;323(1):C29\u201345.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"579_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12920-023-01726-1","volume":"16","author":"J Deng","year":"2023","unstructured":"Deng J, Liao X. Lysine lactylation (Kla) might be a novel therapeutic target for breast cancer. BMC Med Genomics. 2023;16(1):283.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"579_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41423-023-01108-8","volume":"21","author":"A Meyer","year":"2024","unstructured":"Meyer A, Zack SR, Nijim W, Burgos A, Patel V, Zanotti B, et al. Metabolic reprogramming by Syntenin-1 directs RA FLS and endothelial cell-mediated inflammation and angiogenesis. Cell Mol Immunol. 2024;21(1):33\u201346.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"579_CR23","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-11-4149","volume":"72","author":"AG Remacle","year":"2012","unstructured":"Remacle AG, Golubkov VS, Shiryaev SA, Dahl R, Stebbins JL, Chernov AV, et al. Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Res. 2012;72(9):2339\u201349.","journal-title":"Cancer Res"},{"issue":"1","key":"579_CR24","doi-asserted-by":"publisher","first-page":"605","DOI":"10.4049\/jimmunol.0901698","volume":"185","author":"JC Rodr\u00edguez-Prados","year":"2010","unstructured":"Rodr\u00edguez-Prados JC, Trav\u00e9s PG, Cuenca J, Rico D, Aragon\u00e9s J, Mart\u00edn-Sanz P, et al. Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation. J Immunol. 2010;185(1):605\u201314.","journal-title":"J Immunol"},{"issue":"1","key":"579_CR25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12964-020-00678-8","volume":"18","author":"N Saeki","year":"2020","unstructured":"Saeki N, Imai Y. Reprogramming of synovial macrophage metabolism by synovial fibroblasts under inflammatory conditions. Cell Commun Signal. 2020;18(1):188.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"579_CR26","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.arr.2010.08.004","volume":"10","author":"D Frasca","year":"2011","unstructured":"Frasca D, Diaz A, Romero M, Landin AM, Blomberg BB. Age effects on B cells and humoral immunity in humans. Ageing Res Rev. 2011;10(3):330\u20135.","journal-title":"Ageing Res Rev"},{"key":"579_CR27","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"579_CR28","doi-asserted-by":"crossref","unstructured":"Sajan MP, Ivey RA 3rd, Farese RV. Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5\u2019-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression. Diabetologia. 2013;56(11):2507\u201316.","DOI":"10.1007\/s00125-013-3010-1"},{"issue":"24","key":"579_CR29","doi-asserted-by":"publisher","first-page":"e2319301121","DOI":"10.1073\/pnas.2319301121","volume":"121","author":"J Gautheron","year":"2024","unstructured":"Gautheron J, Elsayed S, Pistorio V, Lockhart S, Zammouri J, Auclair M, et al. ADH1B, the adipocyte-enriched alcohol dehydrogenase, plays an essential, cell-autonomous role in human adipogenesis. Proc Natl Acad Sci U S A. 2024;121(24):e2319301121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"579_CR30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41416-022-02066-0","volume":"128","author":"R Vill\u00e9ger","year":"2023","unstructured":"Vill\u00e9ger R, Chulkina M, Mifflin RC, Markov NS, Trieu J, Sinha M, et al. Loss of alcohol dehydrogenase 1B in cancer-associated fibroblasts: contribution to the increase of tumor-promoting IL-6 in colon cancer. Br J Cancer. 2023;128(4):537\u201348.","journal-title":"Br J Cancer"},{"issue":"4","key":"579_CR31","doi-asserted-by":"publisher","first-page":"e202451381","DOI":"10.1002\/eji.202451381","volume":"55","author":"\u00d3C Henry","year":"2025","unstructured":"Henry \u00d3C, O\u2019Neill LAJ. Metabolic reprogramming in stromal and immune cells in rheumatoid arthritis and osteoarthritis: therapeutic possibilities. Eur J Immunol. 2025;55(4):e202451381.","journal-title":"Eur J Immunol"},{"key":"579_CR32","doi-asserted-by":"crossref","unstructured":"Kong H, Han J, Guo L, Zhang XA. Targeting post-translational modifications: novel insights into bone metabolic diseases. J Adv Res. 2025.","DOI":"10.1016\/j.jare.2025.06.020"},{"key":"579_CR33","doi-asserted-by":"crossref","unstructured":"Bastian K, Scott E, Elliott DJ, Munkley J. FUT8 Alpha-(1,6)-Fucosyltransferase in cancer. Int J Mol Sci. 2021; 22(1).","DOI":"10.3390\/ijms22010455"},{"issue":"7","key":"579_CR34","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1053\/j.gastro.2016.03.002","volume":"150","author":"H Fujii","year":"2016","unstructured":"Fujii H, Shinzaki S, Iijima H, Wakamatsu K, Iwamoto C, Sobajima T, et al. Core fucosylation on T cells, required for activation of T-Cell receptor signaling and induction of colitis in mice, is increased in patients with inflammatory bowel disease. Gastroenterology. 2016;150(7):1620\u201332.","journal-title":"Gastroenterology"},{"issue":"1","key":"579_CR35","doi-asserted-by":"publisher","first-page":"e1003225","DOI":"10.1371\/journal.pgen.1003225","volume":"9","author":"G Lauc","year":"2013","unstructured":"Lauc G, Huffman JE, Pu\u010di\u0107 M, Zgaga L, Adamczyk B, Mu\u017eini\u0107 A, et al. Loci associated with N-glycosylation of human Immunoglobulin G show Pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet. 2013;9(1):e1003225.","journal-title":"PLoS Genet"},{"key":"579_CR36","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cytogfr.2022.11.001","volume":"68","author":"L Ye","year":"2022","unstructured":"Ye L, Jiang Y, Zhang M. Crosstalk between glucose metabolism, lactate production and immune response modulation. Cytokine Growth Factor Rev. 2022;68:81\u201392.","journal-title":"Cytokine Growth Factor Rev"},{"key":"579_CR37","doi-asserted-by":"publisher","first-page":"111913","DOI":"10.1016\/j.intimp.2024.111913","volume":"132","author":"PR Gan","year":"2024","unstructured":"Gan PR, Wu H, Zhu YL, Shu Y, Wei Y. Glycolysis, a driving force of rheumatoid arthritis. Int Immunopharmacol. 2024;132:111913.","journal-title":"Int Immunopharmacol"},{"key":"579_CR38","doi-asserted-by":"crossref","unstructured":"Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Cyclophosphamide for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;20002:Cd001157.","DOI":"10.1002\/14651858.CD001157"},{"issue":"1","key":"579_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4196\/kjpp.24.079","volume":"29","author":"M Xin","year":"2025","unstructured":"Xin M, Jin H, Guo X, Zhao L, Li X, Xu D, et al. Retinoic acid ameliorates rheumatoid arthritis by attenuating inflammation and modulating macrophage polarization through MKP-1\/MAPK signaling pathway. Korean J Physiol Pharmacol. 2025;29(1):45\u201356.","journal-title":"Korean J Physiol Pharmacol"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00579-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00579-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:10:08Z","timestamp":1783480208000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41065-025-00579-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00579-1","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"1 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}